Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Extended gene panel testing in lobular breast cancer.

Familial cancer - 1 Apr 2022

van Veen Elke M, Evans D Gareth, Harkness Elaine F, Byers Helen J, Ellingford Jamie M, Woodward Emma R, Bowers Naomi L, Wallace Andrew J, Howell Sacha J, Howell Anthony, Lalloo Fiona, Newman William G, Smith Miriam J

Abstract excerpt

PURPOSE: Lobular breast cancer (LBC) accounts for ~ 15% of breast cancer. Here, we studied the frequency of pathogenic germline variants (PGVs) in an extended panel of genes in women affected with LBC. METHODS: 302 women with LBC and 1567 without breast cancer were tested for BRCA1/2 PGVs. A subset of 134 LBC affected women who tested negative for BRCA1/2 PGVs underwent extended screening, including: ATM, CDH1,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Genes, BRCA2

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Predisposition to Disease

Share to Genetic Testing

Share to Germ-Line Mutation

Source

Open in PubMed Open full text

Identifiers

PMID: 33763779
DOI: 10.1007/s10689-021-00241-5
PMCID: PMC8964550

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Extended gene panel testing in lobular breast cancer.PMID 33763779Read ↗

Germline Pathogenic Variants in Cancer Predisposition Genes Among Women With Invasive Lobular Carcinoma of the Breast.Semantic proximity Read ↗

Gene panel testing of 5589 BRCA1/2-negative index patients with breast cancer in a routine diagnostic setting: results of the German Consortium for Hereditary Breast and Ovarian Cancer.Semantic proximity Read ↗

Genetic risk assessment and prevention: the role of genetic testing panels in breast cancer.Semantic proximity Read ↗

A study of over 35,000 women with breast cancer tested with a 25‐gene panel of hereditary cancer genesSemantic proximity Read ↗

Germline Multigene Panel Testing in Women With Invasive Lobular Cancer.Semantic proximity Read ↗

Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer.Semantic proximity Read ↗

Targeted massively parallel sequencing of a panel of putative breast cancer susceptibility genes in a large cohort of multiple-case breast and ovarian cancer families.Semantic proximity Read ↗

Gene panel sequencing in familial breast/ovarian cancer patients identifies multiple novel mutations also in genes others than BRCA1/2.Semantic proximity Read ↗

Investigation of monogenic causes of familial breast cancer: data from the BEACCON case-control studySemantic proximity Read ↗

Frequency of Pathogenic Germline Variants in CDH1, BRCA2, CHEK2, PALB2, BRCA1 , and TP53 in Sporadic Lobular Breast CancerSemantic proximity Read ↗

Functions of Breast Cancer Predisposition Genes: Implications for Clinical Management.Semantic proximity Read ↗

Association of Family Cancer History With Pathogenic Variants in Specific Breast Cancer Susceptibility Genes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.